Gemfibrozil-lovastatin therapy for primary hyperlipoproteinemias
- 1 July 1992
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 70 (1) , 1-9
- https://doi.org/10.1016/0002-9149(92)91380-m
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Regression of femoral atherosclerosis.Circulation, 1991
- Beneficial Effects of Colestipol-Niacin on Coronary AtherosclerosisPublished by American Medical Association (AMA) ,1990
- Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein BNew England Journal of Medicine, 1990
- Published by Massachusetts Medical Society ,1990
- Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsArchives of internal medicine (1960), 1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacinJournal of the American College of Cardiology, 1986
- Lowering Blood Cholesterol to Prevent Heart DiseaseJAMA, 1985
- Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.Circulation, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984